BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Aug. 18, 2004
View Archived Issues
Evolva Raises EUR12M To Drive Molecular Evolution Platform
Evolva SA raised €12 million in a Series A round to further develop its Watchmaker platform, which employs yeast artificial chromosomes and flow cytometry for the synthesis and selection of novel compounds. (BioWorld International)
Read More
UK Clears Cloning Embryos For Extraction Of Stem Cells
Read More
Immune System Genes Merge To Beat Back Hepatitis C Virus
Read More
Lynx, Solexa Eyeing Merger After Gaining DNA Clusters
Read More
TopoTarget, NeuroSearch Form Agreement Around Cancer Drug
Read More
New Faces Constructing New EU Biotechnology Guidelines
Read More
Other News To Note
Read More